On April 27, 2024, the East African Newspaper featured the Ifakara Health Institute commemorating World Malaria Day. The article highlights Ifakara's pivotal role in advancing malaria prevention efforts, notably through its involvement in the development and evaluation of the R21/Matrix-MTM vaccine. 

The piece highlights the significance of the R21/Matrix-MTM vaccine, which has exhibited promising efficacy in preventing malaria cases, particularly among vulnerable populations in high transmission areas. With backing from the World Health Organization and support from global health alliances like GAVI, endeavors are underway to ensure fair access to the vaccine in malaria-endemic regions.

Ifakara takes great pride in its leadership in vaccine development and clinical trials to transform public health outcomes. As we continue to push the boundaries of scientific discovery, Ifakara remains dedicated to serving as a catalyst for positive change in the fight against malaria and other pressing public health challenges worldwide.

To read the full article click here.